Neuraxis (NRXS) Cash & Equivalents (2022 - 2026)
Neuraxis (NRXS) reported Cash & Equivalents of $8.32 million for Q2 2026, up 39.0% from $5.99 million a year earlier and up 17.6% from the prior quarter.
Powered by 
Analysis
Neuraxis (NRXS) Cash & Equivalents (2022 - 2026) Analysis & Trends
At the end of FY2025, Neuraxis posted Cash & Equivalents of $4.97 million, up 34.3% from FY2024.
- Cash & Equivalents has a three-year compound annual growth rate of 169.5% (FY2022 to FY2025).
- By year, Cash & Equivalents came in at $3.7 million in FY2024, $78,560 in FY2023 (-69.0%) and $253,699 in FY2022.
- The Q2 2026 figure ranks as the highest quarterly Cash & Equivalents in data going back to Q4 2022.
- Year over year, Cash & Equivalents has now increased in each of the last three quarters, with growth averaging 100.0% over the last five quarters.
- Per Business Quant data, the three quarters before Q2 2026 came in at $7.08 million (Q1 2026), $4.97 million (Q4 2025) and $4.38 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 242.18 Bn | 221.33 Bn | 4.88 Bn | 4.06 Bn |
| 2 | Abbott Laboratories | 168.71 Bn | 139.79 Bn | 7.27 Bn | 5.10 Bn |
| 3 | Danaher | 150.46 Bn | 134.27 Bn | 3.61 Bn | 4.35 Bn |
| 4 | Intuitive Surgical | 138.71 Bn | 118.26 Bn | 1.96 Bn | 2.76 Bn |
| 5 | Medtronic | 110.54 Bn | 76.41 Bn | 6.34 Bn | 1.69 Bn |
| 6 | Stryker | 105.66 Bn | 91.78 Bn | 4.50 Bn | 3.39 Bn |
| 7 | Boston Scientific | 61.74 Bn | 56.75 Bn | 3.85 Bn | 539.00 Mn |
| 8 | Edwards Lifesciences | 49.09 Bn | 33.21 Bn | 1.35 Bn | 2.91 Bn |
| 9 | Becton Dickinson | 48.16 Bn | 45.31 Bn | 2.32 Bn | 708.00 Mn |
| 10 | Neuraxis | 88.77 Mn | 64.03 Mn | - | 8.32 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.32 Mn |
| Mar 31, 2026 | 7.08 Mn |
| Dec 31, 2025 | 4.97 Mn |
| Sep 30, 2025 | 4.38 Mn |
| Jun 30, 2025 | 5.99 Mn |
| Mar 31, 2025 | 2.01 Mn |
| Dec 31, 2024 | 3.70 Mn |
| Sep 30, 2024 | 260,885.00 |
| Jun 30, 2024 | 1.77 Mn |
| Mar 31, 2024 | 81,752.00 |
| Dec 31, 2023 | 78,560.00 |
| Sep 30, 2023 | 761,249.00 |
| Jun 30, 2023 | 51,440.00 |
| Dec 31, 2022 | 253,699.00 |
API Access
Neuraxis Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=NRXS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "NRXS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=NRXS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();